University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Teresa De Marco, M.D.

Director of Advanced Heart Failure and Pulmonary Hypertension
Medical Director of Heart Transplantation

Dr. Teresa De Marco is director of advanced heart failure and pulmonary hypertension and medical director of heart transplantation. She manages patients with advanced heart failure and pulmonary hypertension and is an expert in all treatment modalities for the conditions. She participates in multi-center studies evaluating state-of-the-art options for advanced disease states.

De Marco was certified in 2010 by the American Board of Internal Medicine in advanced heart failure and transplant cardiology. She earned a medical degree at the University of California at Irvine after graduating from the University of California at Berkeley. She completed an internship in internal medicine and a residency in internal medicine at UCSF Medical Center. She also completed fellowships in cardiology and heart transplantation. She is a professor of medicine and surgery at UCSF.

Clinics

Advanced Heart Failure Evaluation and Therapies Program
400 Parnassus Ave., Sixth Floor, Suite A-6110
San Francisco, CA 94143-0118
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday
8 a.m. – 3 p.m.

Cardiovascular Genetics Program
400 Parnassus Avenue, Plaza Level, Room 94
San Francisco, CA 94143
Phone: (415) 353-2873
Fax: (415) 476-5355

Hours: Monday
noon – 4 p.m

Heart Transplant Program
400 Parnassus Ave., Sixth Floor
San Francisco, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday 8 a.m. – 5 p.m. (times vary depending on the number of doctors in clinic)

HHT Center of Excellence
185 Berry St., Suite 180, Lobby 6
San Francisco, CA 94107
Phone: (415) 353-8867
Fax: (415) 353-3158

Hours: Monday to Friday,
8 a.m. – 4:30 p.m.

Pulmonary Hypertension Clinic
400 Parnassus Ave., Plaza Level
San Francisco, CA 94143
Phone: (415) 353-9088
Fax: (415) 353-3889

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

Conditions & Treatments

More about Teresa De Marco

Additional Languages

Italian
Spanish

Education

UC Irvine School of Medicine 1982

Residencies

UCSF Medical Center, Internal Medicine 1985

Fellowships

UCSF Medical Center, Heart Failure 1987
UCSF Medical Center, Cardiovascular Disease 1989

Selected Research and Publications

  1. Johnson CJ, Roberts JD, James JH, Hoffmayer KS, Badhwar N, Ku IA, Zhao S, Naeger DM, Rao RK, O'Connell JW, De Marco T, Botvinick EH, Scheinman MM. Comparison of radionuclide angiographic synchrony analysis to echocardiography and magnetic resonance imaging for the diagnosis of arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2015 Jun; 12(6):1268-75.
  2. Naeger DM, Higgins C, De Marco T, Muzzarelli S, Ordovas KG. Low-intensity late gadolinium enhancement predominates in hypertrophic cardiomyopathy. Clin Imaging. 2015 May-Jun; 39(3):432-6.
  3. Deo RC, Musso G, Tasan M, Tang P, Poon A, Yuan C, Felix JF, Vasan RS, Beroukhim R, De Marco T, Kwok PY, MacRae CA, Roth FP. Prioritizing causal disease genes using unbiased genomic features. Genome Biol. 2014; 15(12):534.
  4. Tampakakis E, Leary PJ, Selby VN, De Marco T, Cappola TP, Felker GM, Russell SD, Kasper EK, Tedford RJ. The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JACC Heart Fail. 2015 Jan; 3(1):9-16.
  5. Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs JS, Martinez F, Semigran M, Simonneau G, Wells A, Seeger W. [Pulmonary hypertension due to left heart diseases]. Turk Kardiyol Dern Ars. 2014 Oct; 42 Suppl 1:130-41.
  6. Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéy JL. [Pulmonary hypertension in chronic lung diseases]. Turk Kardiyol Dern Ars. 2014 Oct; 42 Suppl 1:142-52.
  7. Cogswell R, Pritzker M, De Marco T. Performance of the REVEAL pulmonary arterial hypertension prediction model using non-invasive and routinely measured parameters. J Heart Lung Transplant. 2014 Apr; 33(4):382-7.
  8. Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs JS, Martinez F, Semigran M, Simonneau G, Wells A, Seeger W. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol. 2013 Dec 24; 62(25 Suppl):D100-8.
  9. Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéry JL. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol. 2013 Dec 24; 62(25 Suppl):D109-16.
  10. Markova SM, De Marco T, Bendjilali N, Kobashigawa EA, Mefford J, Sodhi J, Le H, Zhang C, Halladay J, Rettie AE, Khojasteh C, McGlothlin D, Wu AH, Hsueh WC, Witte JS, Schwartz JB, Kroetz DL. Association of CYP2C9*2 with bosentan-induced liver injury. Clin Pharmacol Ther. 2013 Dec; 94(6):678-86.
  11. Cogswell R, McGlothlin D, Kobashigawa E, Shaw R, De Marco T. Performance of the REVEAL model in WHO Group 2 to 5 pulmonary hypertension: application beyond pulmonary arterial hypertension. J Heart Lung Transplant. 2013 Mar; 32(3):293-8.
  12. Cogswell R, Kobashigawa E, McGlothlin D, Shaw R, De Marco T. Validation of the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survival. J Heart Lung Transplant. 2012 Nov; 31(11):1165-70.
  13. Roubinian N, Elliott CG, Barnett CF, Blanc PD, Chen J, De Marco T, Chen H. Effects of commercial air travel on patients with pulmonary hypertension air travel and pulmonary hypertension. Chest. 2012 Oct; 142(4):885-92.
  14. Barnett CF, De Marco T. Pulmonary hypertension associated with left-sided heart disease. Heart Fail Clin. 2012 Jul; 8(3):447-59.
  15. Hong TT, Cogswell R, James CA, Kang G, Pullinger CR, Malloy MJ, Kane JP, Wojciak J, Calkins H, Scheinman MM, Tseng ZH, Ganz P, De Marco T, Judge DP, Shaw RM. Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2012 Jun; 9(6):961-7.
  16. Barnett CF, De Marco T. A chocolate a day keeps the doctor away? J Physiol. 2011 Dec 15; 589(Pt 24):5921-2.
  17. Weeks SG, Glantz SA, De Marco T, Rosen AB, Fleischmann KE. Secondhand smoke exposure and quality of life in patients with heart failure. Arch Intern Med. 2011 Nov 28; 171(21):1887-93.
  18. Koskenvuo JW, Mirsky R, Zhang Y, Helenius H, Angeli FS, De Marco T, Boyle AJ, Yeghiazarians Y. Evidence of diminished coronary flow in pulmonary hypertension: explaining angina pectoris in this patient group? Clin Physiol Funct Imaging. 2011 Nov; 31(6):477-84.
  19. Barnett CF, De Marco T. Can pulmonary arterial hypertension be diagnosed by an elevated pulmonary capillary wedge pressure outside of the guideline criteria? Chest. 2011 Sep; 140(3):828-9; author reply 829-30.
  20. Caleshu C, Sakhuja R, Nussbaum RL, Schiller NB, Ursell PC, Eng C, De Marco T, McGlothlin D, Burchard EG, Rame JE. Furthering the link between the sarcomere and primary cardiomyopathies: restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy. Am J Med Genet A. 2011 Sep; 155A(9):2229-35.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.